Drug intelligence / Profile preview

wild type feline HER2 DNA vaccine

Development stage
Unknown
Lead developer
Wayne State University
Modality
Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intramuscular
01

Overview

The wild type feline HER2 DNA vaccine is a research-stage DNA vaccine construct encoding the unmodified (wild-type) feline HER2 protein. Developed by researchers at Wayne State University, it has been evaluated in outbred domestic cats as a potential veterinary immunotherapy for feline mammary carcinoma and as a comparative model for human breast cancer vaccines. The vaccine is administered via intramuscular electrovaccination (electroporation) to stimulate an immune response against HER2-overexpressing tumor cells. However, preclinical studies have shown that the wild-type construct has a limited ability to overcome immune tolerance compared to heterologous or point-mutated feline HER2 DNA vaccine variants, and it may even hinder immune activation by other vaccines.

Other names
pfeHER2pfeHER-2pfeHER 2wild-type feline HER2 DNA vaccine
02

Targets

ERBB3 (Erb-b2 receptor tyrosine kinase 3)HER2 (Receptor tyrosine-protein kinase erbB-2)ERBB2 (Erb-b2 receptor tyrosine kinase 2)

Beyond the preview

Go deeper on wild type feline HER2 DNA vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on wild type feline HER2 DNA vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call